Peter C. Brandt, President and CEO at NOVEN PHARMACEUTICALS INC (NOVN), bought 25,000 shares at $9.73 ($245K) on 2008-05-13, disclosed to the SEC on 2008-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.69 | 200 | $2K | 0.8% |
| 2 | $9.73 | 1,000 | $10K | 4.0% |
| 3 | $9.79 | 916 | $9K | 3.7% |
| 4 | $9.86 | 2,884 | $28K | 11.6% |
| 5 | $9.76 | 10,000 | $98K | 39.9% |
| 6 | $9.82 | 10,000 |
| $98K |
| 40.1% |
| Total | $9.79 avg | 25,000 | $245K | 100% |
| Filing → |
| RNN | BUY | 2011-09-12 | $147K | — | Filing → |
| EPOC | BUY | 2011-09-09 | $142K | — | Filing → |
| EPOC | BUY | 2011-09-08 | $100K | — | Filing → |